Table I.
Characteristics | Patient no. (%) |
---|---|
Gender | |
Male | 18 (58) |
Female | 13 (42) |
Age, years | |
Median (range) | 57 (35–77) |
70–79 | 8 (26) |
60–69 | 8 (26) |
<60 | 15 (48) |
ECOG performance status | |
0 | 3 (10) |
1 | 10 (32) |
2 | 13 (42) |
3 | 5 (16) |
Tumour location | |
Head | 22 (71) |
Body-tail | 9 (29) |
Maximum tumour diameter, cm | |
Median (range) | 5.12 (2.2–11) |
Metastases | |
M0 | 26 (84) |
M1 | 5 (16) |
Histological diagnosis | |
Adenocarcinoma | 29 (94) |
Others | 2 (6) |
Differentiation | |
High | 14 (45) |
Moderate | 3 (10) |
Poor | 2 (6) |
Not defined | 12 (39) |
Percent weight loss | |
<10% | 21(68) |
No loss | 10 (32) |
Presenting symptoms prior to RTa | |
Jaundice | 2 (6) |
Abdominal pain | 21 (68) |
Fatigue | 7 (23) |
Diarrhoea | 10 (32) |
Back pain | 10 (32) |
Patients with multiple presenting symptoms; the major symptoms are listed. ECOG, Eastern Cooperative Oncology Group; M0, locally advanced; M1, metastatic; RT, radiotherapy.